Peter Mesenbrink
1 appearance in the program
Sessions & presentations
PS41: Overcoming Obstacles in Using Hybrid Controls in Phase 2/3 Clinical Trials as the Basis for Regulatory Approval
Organizer
Parallel · Fri, Sep 26 , 1:30 PM